A number of hypotheses have been proposed to justify the anomalous expression of P-cadherin by breast cancer cells, namely, the oncofetal properties of P-cadherin protein [37], its histogenetic origin in cap cells or acquisition of a stem cell like phenotype [68, 74]. Here, CDH3 is linked to breast cancer.